Cells, 2024 · DOI: 10.3390/cells13020153 · Published: January 15, 2024
The intervertebral disc (IVD) is a soft tissue that constitutes the spinal column together with the vertebrae, and consists of the central nucleus pulposus (gelatinous tissue) and the annulus fibrosus (rich in fibrous tissue) that surrounds the nucleus pulposus. The increasing incidence of IVD degeneration with age and its correlation with lower back pain, IVD herniation, and spinal canal stenosis is a remarkable trend in contemporary society. This Special Issue aimed to report the current knowledge on the molecular mechanisms of degeneration and regeneration of the IVD for new treatment strategies.
The research provides insights into new molecular targets for treating IVD degeneration, such as mir-107/Wnt3a-β-catenin signaling and ferroptosis.
Mesenchymal stem cells and scaffolds can be used to regenerate intervertebral disc cells, providing a basis for regenerative therapies.
Injection of ultra-purified stem cells with sodium alginate may reduce discogenic pain, offering a potential alternative to surgical treatments.